FDA Drug Recalls

Recalls / Class II

Class IID-1352-2015

Product

Hydrochlorothiazide Tablet USP 25 mg,1000- count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Marketed by: UNICHEM PHARMACEUTICALS (USA), INC. Rochelle Park, NJ 07662, NDC 29300-128-10

Brand name
Hydrochlorothiazide
Generic name
Hydrochlorothiazide
Active ingredient
Hydrochlorothiazide
Route
Oral
NDCs
29300-128, 29300-129, 29300-485
FDA application
ANDA040907
Affected lot / code info
Lot #: GHYL15028, Exp April 2018

Why it was recalled

Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in the 1000-count bottle of hydrochlorothiazide 25 mg tablets.

Recalling firm

Firm
Unichem Pharmaceuticals Usa Inc
Manufacturer
Unichem Pharmaceuticals (USA), Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
201 W Passaic St Ste 403, N/A, Rochelle Park, New Jersey 07662-3128

Distribution

Quantity
4776 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-07-30
FDA classified
2015-08-25
Posted by FDA
2015-09-02
Terminated
2018-10-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1352-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Hydrochlorothiazide · FDA Drug Recalls